High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.
about
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressureCrystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid moleculesFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewOverexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient miceA note on a nonparametric regression test through penalized splinesModel system for the analysis of cell surface expression of human ABCA1.Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study.Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometryCritical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populationsQuantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry.Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.Aggregation and fusion of low-density lipoproteins in vivo and in vitro.Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.Association of the LIPG 584C > T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.High density lipoproteins-based therapies for cardiovascular disease.Association of methylenetetrahydrofolate reductase C677T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populationsThe common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.Polymorphism of rs1044925 in the acyl-CoA:cholesterol acyltransferase-1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.Current practice in the treatment of hyperlipidaemias.The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populationsA genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI.Low density lipoprotein receptor gene Ava II polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.Management of dyslipidemia in women in the post-hormone therapy era.Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis.Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.Characteristics of high-density lipoprotein subclasses distribution for subjects with desirable total cholesterol levelsPolymorphisms of mouse apolipoprotein A-II alter its physical and functional nature.High prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMI.MicroRNA control of high-density lipoprotein metabolism and functionUpdate on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.What's new in lipid management?Atherosclerosis and physical activity.Association of the TRIB1 tribbles homolog 1 gene rs17321515 A>G polymorphism and serum lipid levels in the Mulao and Han populations.Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid TransportHigh-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake
P2860
Q24624286-BB2C23C0-760B-4F32-9C89-9AA37E4882A6Q27643587-262E46B6-FFCC-49E6-9605-67DB29B868DDQ28220294-0CF552AE-F6B2-4FC3-9C9B-201AD7775264Q28513365-7A48547F-6B1E-440C-9984-6765FE3985F0Q28655269-ED9B9B8D-5B70-4619-AD90-362FBB14D158Q33520103-556EBD1E-3763-4BC1-905F-9F36BCF075FEQ33663533-9595AF5C-A008-4D8A-AF77-575E3C778FE7Q33675323-401AEB1C-0DFB-4186-AAB7-9DF32FF2F4CAQ33802196-17285615-181A-4ECC-BE2D-66A8FEE1EDF8Q33905987-C4E56450-3622-45D3-B073-0DEC74A7F1B1Q34010887-030D1E4A-37D1-4157-A3CA-34A4092E11D6Q34053599-614C7A67-14AB-433C-934B-0E64B6F5F7BCQ34120778-0FA1F3AF-E610-4A23-9722-8D9E9EACB4FAQ34133240-571DCC1F-FF69-44A2-A5EB-EC98909A945DQ34160333-515F2436-F0E8-4CB9-8214-0EFC0120A918Q34292682-04C3EE37-1AB8-4A3C-BBC7-EE699AF6C35CQ34313937-9B5E138D-4724-43B8-9237-282987F71EC0Q34331985-B090119A-3E64-4B03-80B3-3EBCA3BB3BBFQ34383825-F860732A-9FA5-49AE-99BB-9BE6E54749B0Q34499464-F0B313ED-5BAE-4EB7-992F-AED7429301B7Q34515467-76935C9A-DDDA-4AC9-8097-5DF044779D58Q34559768-5082C3BD-DE12-45C3-8D2E-AAE4ECC7DC49Q34559909-38147A0C-D0AC-4A55-AC2B-915BBE3581D6Q34628675-A56EC6F5-830F-49A3-A33B-F531C7598E65Q34644974-009ECBF8-1AA1-4884-B28A-3C7DF4449172Q34722828-D28CFF98-D73A-4924-BB04-C579811C4434Q35014329-E5FE0B8A-E949-4775-B1C8-76BBA5AC33C3Q35026444-437B664D-BA20-4920-888B-0EEC00F47D3DQ35031323-72D6A387-967C-4AD7-B4E1-37ABD0E609EBQ35092902-086EE46F-AA77-4DFF-A36C-3CF8A9F4F3DAQ35155152-CFF43D31-C2CA-4D04-BFFE-3C52517A4B28Q35200081-00228DC5-71E4-40ED-9764-AE116F354D92Q35549732-729BAA56-5705-46DD-A900-F71DCEB4EAD6Q35549738-8B48835E-3068-4722-955F-B46FB0BB053BQ35651476-42826FD6-D4F4-4ECD-8E30-8171C2D90412Q35763488-D06CB25C-6D7F-4216-AFCB-AF27367B45D1Q35791953-ECE7EC60-9D45-4B24-B6E5-6CB0EE3964F4Q35811972-6FD4A518-A11F-46CB-AAA9-2FE87F0FFB84Q35844499-0BB11550-7998-4B4D-8A7F-8DB6BA089D62Q35860634-06DA1C6B-4E73-409A-BA74-E9682BC81868
P2860
High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@ast
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@en
type
label
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@ast
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@en
prefLabel
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@ast
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@en
P921
P1476
High-density lipoprotein chole ...... ipoprotein Intervention Trial.
@en
P2093
P304
P356
10.1016/S0002-9149(00)01464-8
P407
P577
2000-12-01T00:00:00Z